ÙSurgical site infection was assessed Superficial,
Conditions
Interventions
cefalexin 500mg every 6 hours and clindamycin 300 mg every 6 hours up to 48 hours after the second day after cesarean section ,Control group did not take any medication out of routine drugs
Active Comparator Drug,Active Comparator Drug
cefalexin and clindamycin,cefazolin
Sponsors
Urmia University of Medical Sciences
Urmia University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All participants with emergency cesarean section, satisfied to participate without any sensitivity to antibiotics.
Exclusion criteria
Exclusion criteria: Exclusion criteria were receiving antibiotics in addition to routine cefazolin, intraoperative atony event, placenta previa, decolonization, massive bleeding leading to blood transfusion, BMI> 35 kg/m2, taking immunosuppressive drugs and corticosteroids, known underlying diseases including autoimmune, lymphoblastic, rheumatological and cardiac diseases, elective cesarean section, febrile patients at the time of hospitalization
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of surgical site infection start of the project, visit on day 7-10 and follow-up on day 30. Observation | — |
Secondary
| Measure | Time frame |
|---|---|
| HbA1C start of the project, visit on day 7-10 and follow-up on day 30. Blood sample | — |
Countries
Iran
Contacts
Public ContactShabnam Vazifekhah
Urmia University of Medical Sciences
Outcome results
None listed